Search hospitals > Massachusetts > Boston

Boston Children's Hospital

Claim this profile
Boston, Massachusetts 02115
Global Leader in Post-Implantation Syndrome
Global Leader in Cystic Fibrosis
Conducts research for Fibrosing Colonopathy
Conducts research for Congenital Heart Diseases
Conducts research for Heart Disease
1223 reported clinical trials
124 medical researchers
Photo of Boston Children's Hospital in BostonPhoto of Boston Children's Hospital in BostonPhoto of Boston Children's Hospital in Boston

Summary

Boston Children's Hospital is a medical facility located in Boston, Massachusetts. This center is recognized for care of Post-Implantation Syndrome, Cystic Fibrosis, Fibrosing Colonopathy, Congenital Heart Diseases, Heart Disease and other specialties. Boston Children's Hospital is involved with conducting 1,223 clinical trials across 1,560 conditions. There are 124 research doctors associated with this hospital, such as Susan Chi, MD, Dr. David Brown, Katherine A. Janeway, and Steven G. DuBois, MD, MS.

Area of expertise

1Post-Implantation Syndrome
Global Leader
Boston Children's Hospital has run 119 trials for Post-Implantation Syndrome. Some of their research focus areas include:
FMR1 positive
UBE3A positive
RyR2 positive
2Cystic Fibrosis
Global Leader
Boston Children's Hospital has run 94 trials for Cystic Fibrosis. Some of their research focus areas include:
CFTR
CFTR positive
3849+10Kb C->T positive

Top PIs

Clinical Trials running at Boston Children's Hospital

Crohn's Disease
Post-Implantation Syndrome
Ulcerative Colitis
Psychogenic Colitis
Ulcer
Colitis
Type 1 Diabetes
Liver Cancer
Postoperative Pain
Chronic Kidney Disease
Image of trial facility.

Vedolizumab

for Ulcerative Colitis and Crohn's Disease

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Recruiting3 awards Phase 3
Image of trial facility.

Vedolizumab

for Crohn's Disease

Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be treated with vedolizumab. The main aim of the study is to check if participants achieve remission after treatment with the vedolizumab. Remission means symptoms improve or disappear and an endoscopy shows no signs of inflammation. Participants will receive 3 infusions of vedolizumab over 6 weeks. Then, those who have a clinical response will receive either a high dose or low dose of vedolizumab once every 8 weeks. They will receive the same dose every time.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Guselkumab

for Pediatric Crohn's Disease

This trial tests guselkumab, an anti-inflammatory medication, on children with Crohn's Disease who initially responded well to it. The goal is to see if the benefits last over several months by reducing immune system activity. Guselkumab has shown effectiveness in treating moderate-to-severe psoriasis and psoriatic arthritis.
Recruiting2 awards Phase 3

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Boston Children's Hospital?
Where is Boston Children's Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Boston Children's Hospital accept?
What awards or recognition has Boston Children's Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security